Curis (CRIS) Change in Receivables (2010 - 2025)
Curis (CRIS) reported Change in Receivables of $1.1 million for Q4 2025, up 206.74% on a YoY basis from $371000.0 in Q4 2024, and up 131.77% quarter-over-quarter from $491000.0 in Q3 2025.
Curis (CRIS) Change in Receivables (2010 - 2025) Analysis & Trends
Curis has reported Change in Receivables for 16 years, with the latest figure at $1.1 million in Q4 2025.
- For the quarter ending Q4 2025, Change in Receivables rose 206.74% year-over-year to $1.1 million; the trailing twelve-month figure through Mar 2026 stood at $2.1 million (up 1183.23% YoY), and the FY2025 full-year result was $1.0 million, up 85.95% from the prior year.
- Change in Receivables for Q4 2025 stood at $1.1 million, up from $491000.0 in the prior quarter.
- The five-year high for Change in Receivables was $1.1 million in Q4 2025, with the low at -$1.2 million in Q1 2022.
- Historically, Change in Receivables has averaged $66900.0 across 5 years, with a median of $300000.0 in 2021.
- Annual changes were most pronounced in 2021 — Change in Receivables surged 1033.33% — and 2023, when it slumped 160.67%.
- Curis' Change in Receivables stood at $265000.0 in 2021, then plunged by 66.42% to $89000.0 in 2022, then slumped by 160.67% to -$54000.0 in 2023, then soared by 787.04% to $371000.0 in 2024, then jumped by 206.74% to $1.1 million in 2025.
- The last three Change in Receivables figures came in at $1.1 million (Q4 2025), $491000.0 (Q3 2025), and $437000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | 22,529.00 |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | -39.80 Mn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | -4.08 Mn |
| 10 | Curis | 8.58 Mn | -6.42 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.14 Mn |
| Dec 31, 2025 | 1.14 Mn |
| Sep 30, 2025 | 491,000.00 |
| Sep 30, 2025 | 491,000.00 |
| Jun 30, 2025 | 437,000.00 |
| Jun 30, 2025 | 437,000.00 |
| Mar 31, 2025 | -1.03 Mn |
| Mar 31, 2025 | -1.03 Mn |
| Dec 31, 2024 | 371,000.00 |
| Dec 31, 2024 | 371,000.00 |
| Sep 30, 2024 | 432,000.00 |
| Sep 30, 2024 | 432,000.00 |
| Jun 30, 2024 | 392,000.00 |
| Jun 30, 2024 | 392,000.00 |
| Mar 31, 2024 | -640,000.00 |
| Mar 31, 2024 | -640,000.00 |
| Dec 31, 2023 | -54,000.00 |
| Dec 31, 2023 | -54,000.00 |
| Sep 30, 2023 | 462,000.00 |
| Sep 30, 2023 | 462,000.00 |